Home/Filings/4/0000874716-25-000137
4//SEC Filing

Hunt Nimrata 4

Accession 0000874716-25-000137

CIK 0000874716other

Filed

Aug 12, 8:00 PM ET

Accepted

Aug 13, 5:17 PM ET

Size

15.9 KB

Accession

0000874716-25-000137

Insider Transaction Report

Form 4
Period: 2025-08-11
Hunt Nimrata
Executive Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2025-08-12$206.94/sh+483$99,95217,849.944 total
  • Exercise/Conversion

    Common Stock

    2025-08-12$544.08/sh+183$99,56718,032.944 total
  • Sale

    Common Stock

    2025-08-11$656.53/sh1,200$787,84016,806.944 total
  • Exercise/Conversion

    Incentive Stock Option (right-to-buy)

    2025-08-125600 total
    Exercise: $178.26Exp: 2028-02-13Common Stock (560 underlying)
  • Exercise/Conversion

    Incentive Stock Option (right-to-buy)

    2025-08-121830 total
    Exercise: $544.08Exp: 2031-02-13Common Stock (183 underlying)
  • Exercise/Conversion

    Common Stock

    2025-08-12$178.26/sh+560$99,82617,366.944 total
  • Exercise/Conversion

    Incentive Stock Option (right-to-buy)

    2025-08-124830 total
    Exercise: $206.94Exp: 2029-02-13Common Stock (483 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    160
Footnotes (3)
  • [F1]Grant of option to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2023.
  • [F2]Grant of option to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2024.
  • [F3]Grant of option to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2025.

Issuer

IDEXX LABORATORIES INC /DE

CIK 0000874716

Entity typeother

Related Parties

1
  • filerCIK 0001800619

Filing Metadata

Form type
4
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 5:17 PM ET
Size
15.9 KB